Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Pfizer’s Lipitor Losing U.K. Patent Protection, the Times Says

Pfizer Inc.’s Lipitor, the cholesterol pill that generated about $10.7 billion in sales for the world’s biggest drug maker in 2011, loses patent protection in the U.K. this weekend, the Times reported.

Generic drugs companies can begin to copy the New York-based company’s recipe for the tablet from tomorrow, the Times said, without saying where it got the information. Lipitor lost marketing exclusivity in the U.S. in November and Pfizer reported this month that first-quarter profit fell 19 percent after revenue from the drug declined because of generic competition.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.